[1] Zhang CY, Yuan WG, He P, et al. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol, 2016, 22(48): 10512-10522. [2] Natsuko H, Yasushi T, Fumihito M, et al. Epigenetic landscape influences the liver cancer genome architecture. Nat Commun, 2018, 9: 1643. [3] Andre M, Dirk F, Heinz H. Evaluation of direct haptic 4D volume rendering of partially segmented data for liver puncture simulation. Sci Rep, 2017, 7: 671. [4] Chin JL, Pavlides M, Moolla A, et al. Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy? Front Pharmacol, 2016, 7(159): 1-19. [5] Thilo B, Vincent S, Martin T, et al. Analysis of disease-associated protein expression using quantitative proteomics-fibulin-5 is expressed in association with hepatic fibrosis. J Proteome Res, 2015, 14: 2278-2286. [6] Rabia E, Umit A, Yucel A, et al. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol, 2015, 27: 667-671. [7] Panel AHG. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing and treating adults infected with hepatitis C virus. Hepatology, 2015, 62(3): 932-954. [8] 吴梦平,谢超楠,岳明,等. 血浆25羟基维生素D水平及其受体基因多态性与慢性CHC易感性的相关性研究. 中华疾病控制杂志, 2015, 19(11): 1083-1086, 1091. |